Miglustat Alternatives Compared
| Miglustat | Aqneursa (levacetylleucine) | Levacetylleucine |
|
|---|
| Miglustat | Aqneursa (levacetylleucine) | Levacetylleucine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Niemann-Pick Disease, Gaucher Disease, Pompe Disease. Miglustat may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Niemann-Pick Disease. Aqneursa may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Niemann-Pick Disease. Levacetylleucine may also be used for purposes not listed in this medication guide. |
Related suggestions Niemann-Pick Disease
|
|||||||||||||||
| More about Miglustat | More about Aqneursa (levacetylleucine) | More about Levacetylleucine | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Miglustat has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Miglustat side effects |
View all Aqneursa side effects |
View all Levacetylleucine side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Miglustat prices |
View all Aqneursa prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Opfolda, Yargesa, Zavesca |
N/A |
Aqneursa | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
7 hours |
1 hour |
1 hour |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 1 drugs are known to interact with Miglustat:
|
A total of 84 drugs are known to interact with Aqneursa:
|
A total of 84 drugs are known to interact with Levacetylleucine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
July 31, 2003 |
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.